Zobrazeno 1 - 10
of 2 810
pro vyhledávání: '"Selkirk A"'
Autor:
Alochukwu, Alex S. A., Dossou-Olory, Audace A. V., Osaye, Fadekemi J., Rakotonarivo, Valisoa R. M., Ravichandran, Shashank, Selkirk, Sarah J., Wang, Hua, Whitlatch, Hays
The rank (also known as protection number or leaf-height) of a vertex in a rooted tree is the minimum distance between the vertex and any of its leaf descendants. We consider the sum of ranks over all vertices (known as the security) in binary trees,
Externí odkaz:
http://arxiv.org/abs/2411.19188
Publikováno v:
Combinator. Probab. Comp. 33 (2024) 518-553
The protection number of a vertex $v$ in a tree is the length of the shortest path from $v$ to any leaf contained in the maximal subtree where $v$ is the root. In this paper, we determine the distribution of the maximum protection number of a vertex
Externí odkaz:
http://arxiv.org/abs/2305.09427
Autor:
Pat Dudgeon, Angela Ryder, Jemma Collova, Belle Selkirk, Kate Derry, Colin Hansen, Fred Penny, Cheryl Phillips, Marie Pryor, Margaret Taylor, Joanna Alexi, Ee Pin Chang, Craig D’Mello, Shraddha Kashyap, Monique Platell, Helen Milroy
Publikováno v:
Australian Journal of Psychology, Vol 76, Iss 1 (2024)
Objective Aboriginal Elders have supported Aboriginal health and wellbeing for generations. Aboriginal Elders also play an important role in guiding those who work in health systems to work in culturally safe ways. The Cultural Exchange Program was d
Externí odkaz:
https://doaj.org/article/deaa4dbaf10a47729d8437ccd6def61e
Autor:
Samantha J Anthony, Sarah J Pol, Enid K Selkirk, Amarens Matthiesen, Robert J Klaassen, Dorin Manase, Amanda Silva, Melanie Barwick, Jennifer N Stinson, Alameen Damer, Mowa Ayibiowu, Selina X Dong, Stephan Oreskovich, Michael Brudno
Publikováno v:
JMIR Human Factors, Vol 11, p e57984 (2024)
BackgroundElectronic patient-reported outcome measures (ePROMs) are standardized digital instruments integrated into clinical care to collect subjective data regarding patients’ health-related quality of life, functional status, and symptoms. In do
Externí odkaz:
https://doaj.org/article/654b4b09b4c24e40944a6272a4f430cf
Publikováno v:
BMJ Neurology Open, Vol 6, Iss Suppl 1 (2024)
Externí odkaz:
https://doaj.org/article/4f0b595f8dd54bacbfe7d1e854dfc195
Publikováno v:
Electron. J. Combin.30(2023), no.1, Paper No. 1.26, 18 pp
For fixed non-negative integers $k$, $t$, and $n$, with $t < k$, a $k_t$-Dyck path of length $(k+1)n$ is a lattice path that starts at $(0, 0)$, ends at $((k+1)n, 0)$, stays weakly above the line $y = -t$, and consists of steps from the step-set $\{(
Externí odkaz:
http://arxiv.org/abs/2204.14023
Autor:
Sarah J. Pol, Enid K. Selkirk, Alameen Damer, Istvan Mucsi, Susan Abbey, Beth Edwards, Kenneth Fung, Jagbir Gill, Paula Neves, Suk Yin Ng, Rulan S. Parekh, Linda Wright, Minglin Wu, Samantha J. Anthony
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 11 (2024)
Background: As of 2021, more than 6000 children and youth in Canada were living with end-stage kidney disease (ESKD), for which kidney transplantation is considered the preferred treatment by health professionals. Research shows that living donor kid
Externí odkaz:
https://doaj.org/article/a3fa5c64126442db9177b8119b726986
Autor:
SELKIRK, DIANE
Publikováno v:
Saturday Evening Post. Jul/Aug2024, Vol. 296 Issue 4, p36-41. 6p.
Autor:
Anthony, Samantha J., Lin, Jia, Selkirk, Enid K., Liang, Megan, Ajmera, Faye, Seifert-Hansen, Mirna, Urschel, Simon, Soto, Stephanie, Boucher, Suzanne, Gold, Anna, Stinson, Jennifer N., Ahola Kohut, Sara
Publikováno v:
In Journal of Heart and Lung Transplantation
Autor:
James Spicer, Bristi Basu, Ana Montes, Udai Banerji, Rebecca Kristeleit, Rowan Miller, Gareth J. Veal, Christopher J. Corrigan, Stephen J. Till, Mariangela Figini, Silvana Canevari, Claire Barton, Paul Jones, Sarah Mellor, Simon Carroll, Chris Selkirk, George Nintos, Vineet Kwatra, Ionut-Gabriel Funingana, Gary Doherty, Hannah J. Gould, Giulia Pellizzari, Mano Nakamura, Kristina M. Ilieva, Atousa Khiabany, Chara Stavraka, Jitesh Chauhan, Cheryl Gillett, Sarah Pinder, Heather J. Bax, Debra H. Josephs, Sophia N. Karagiannis
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-11 (2023)
Abstract All antibodies approved for cancer therapy are monoclonal IgGs but the biology of IgE, supported by comparative preclinical data, offers the potential for enhanced effector cell potency. Here we report a Phase I dose escalation trial (NCT025
Externí odkaz:
https://doaj.org/article/10c6fe5134614037a52da348794ee12d